Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics ...
Explore how proteomics in cancer research advances tumor profiling, biomarker discovery, and precision oncology workflows.
Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E Advancements in profiling technologies have deepened our ...
Researchers identify a gene expression program in the living human brain that tracks with real-time neurotransmission, ...
Explore how clinical multi-omics integration drives systems medicine, detailing data fusion methodologies and lab ...
Researchers create a massive single-cell atlas of the aging mouse brain, revealing how epigenetic changes and "jumping genes" drive neurodegeneration.
Translational Molecular Investigations in Oncology: From Dysregulated Expression to Clinical Utility
The field of oncology is currently undergoing a transformation driven by high-throughput proteomics, genomics, and advanced single-cell technologies. These ...
Omics-driven insights into tumor microenvironment determinants of immunotherapy response in melanoma
Immunotherapy has revolutionized cancer treatment, yet response rates remain highly variable across tumor types and individual patients. Increasing evidence ...
Infectious keratitis remains a leading cause of corneal blindness and visual impairment worldwide, with bacterial, fungal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results